Related Experiment Videos
Clusterin prevents aggregation of neuropeptide 106-126 in vitro
1Royal Veterinary College, Royal College Street, London, NW1 OTU, United Kingdom.
Biochemical and Biophysical Research Communications
|June 11, 1999
Abstract:
The prion/amyloid neuropeptide 106-126 spontaneously aggregates to form fibrillar structures in vitro. The aggregation in vitro could be prevented in a dose-related manner by clusterin, and the specificity of this action was confirmed by reversal with antibody to clusterin. The relevance of these observations is discussed in relation to previous observations that clusterin and PrPBSE colocalise in naturally occurring cases of BSE.